| 000 | 01891 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513214815.0 | ||
| 264 | 0 | _c20000925 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1702445 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGertz, M A | |
| 245 | 0 | 0 |
_aDelayed stem cell transplantation for the management of relapsed or refractory multiple myeloma. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cJul 2000 |
||
| 300 |
_a45-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukapheresis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTransplantation, Autologous _xphysiology |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aLacy, M Q | |
| 700 | 1 | _aInwards, D J | |
| 700 | 1 | _aGastineau, D A | |
| 700 | 1 | _aTefferi, A | |
| 700 | 1 | _aChen, M G | |
| 700 | 1 | _aWitzig, T E | |
| 700 | 1 | _aGreipp, P R | |
| 700 | 1 | _aLitzow, M R | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 26 _gno. 1 _gp. 45-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702445 _zAvailable from publisher's website |
| 999 |
_c10868074 _d10868074 |
||